-
article
Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, Olías-Molero AI, Corral MJ, Mateo-Barrientos M, Estaquier J, Pomel S, Alunda JM, Gul S, Van Bocxlaer K, Frézard F, Tavares J, Da Silva AC, Costi MP, Maes L, Caljon G
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
J Antimicrob Chemother
81 (5), 2026.
-
article
Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, Olías-Molero AI, Corral MJ, Mateo-Barrientos M, Estaquier J, Pomel S, Alunda JM, Gul S, Van Bocxlaer K, Frézard F, Tavares J, Cordeiro Da Silva A, Costi MP, Maes L, Caljon G
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
J Antimicrob Chemother
81 (4), 2026.
-
article
Picard M, Boutrais S, Rodrigues V, Fortier Y, Borde C, Soundaramourty C, Clain J, Joly-Beauparlant C, Racine G, Zghidi-Abouzid O, Droit A, Pruvost A, Costi MP, Silvestre R, Cordeiro da Silva A, MacDougall J, André S, Estaquier J
Persistent myeloid cell reprogramming despite miltefosine treatment in leishmania-infected macaques
iScience
28 (12), 2025.